Cancer :: GSK & Synta Pharmaceuticals announce development and commercialisation collaboration for STA-4783 in oncology

GlaxoSmithKline (GSK) and Synta Pharmaceuticals Corp. announced the execution of a global collaboration agreement for the joint development and commercialisation of STA-4783, a first-in-class, small-molecule, oxidative stress inducer that is entering Phase 3 clinical development for the treatment of metastatic melanoma.

Cancer :: Dye test to check response of radiation or chemotherapy in cancer patients

A UNSW researcher has developed a world-first test which will radically improve cancer management. Professor Philip Hogg, the co-director of UNSW’s Lowy Cancer Research Centre, has developed the technology which will determine whether cancer cells are dying within one day of a patient’s treatment with radiation or chemotherapy.

Mosquito :: MIT Holding, Georgia Southern University, and MEVLABS successfully test the PROVECTOR

MIT Holding, Inc. (OTCBB: MITD), in collaboration with MEVLABS and Georgia Southern University, have successfully tested prototype designs of the patent pending PROVECTOR™. This small dispensable device is designed to stop the development of pathogens and parasites found in mosquitoes that carry deadly diseases such as malaria, dengue fever, and West Nile virus.

Antibiotic :: GSK & Anacor Pharmaceuticals form alliance to develop systemic antivirals and antibiotics

GlaxoSmithKline and Anacor Pharmaceuticals announced that they have entered into a worldwide strategic alliance for the discovery, development and commercialisation of novel medicines for viral and bacterial diseases. The collaboration provides GlaxoSmithKline access to Anacor’s proprietary boron-based chemistry for use against selected targets.

Orthopedic :: Ossur leading orthopedic pioneer expands network to Asia

Ossur, a leading provider of noninvasive orthopedic products and services, today announced the inauguration of its Asia Pacific operations in Shanghai, China. Ossur, renowned for its pioneering work in lower-limb prosthetics and a comprehensive range of braces and supports, established its China office as the regional headquarters catering to customers not just in China but across Asia including Japan, South Korea and Australia.

Breast Cancer :: MassMutual to provide donations, education in innovative breast cancer awareness month program

Massachusetts Mutual Life Insurance Company (MassMutual) announced two significant initiatives to support the cause of National Breast Cancer Awareness Month, working to raise awareness and to provide a minimum donation of one hundred thousand dollars to local research, detection and treatment programs.